Prøve GULL - Gratis

India Needs Proper Biosupplier Ecosystem

Bio Spectrum

|

September 2017

With economic growth and addition of biotechnology to its portfolio, India is rapidly becoming a global player in the life sciences and healthcare space. Educating and achieving scientific excellence demands a really high level of R&D. Now that the government is investing more resources in research and medical facilities and infrastructure, from educational institutes to hospitals, use of lab equipment, reagents or medical devices are growing rapidly. This will drive the growth of biosupplier market in the country.

India Needs Proper Biosupplier Ecosystem

India’s life sciences and healthcare industry has changed dramatically in the last decade, moving from import dependency to self-sufficiency, and this has created demand for innovative new technologies. Fueling this growth has been increasing demand from biosuppliers who are challenged to provide innovative and productive solutions that not only support India, but also enable them to compete globally.

Other notable trends in the past few years have been an intensive focus on R&D within pharmaceutical, biotech and healthcare as well as demand from the government sector (mainly R&D institutes). “This has led to new investments in high-end analytical instruments and consumables to support everything from food safety and drug discovery to precision medicine,” said Amit Chopra, Managing Director – India and Middle East, Thermo Fisher Scientific while commenting on trends in biosuppliers market with respect to life sciences and healthcare industry in India.

Biosuppliers are witnessing unprecedented growth opportunities in India due to high growth in the Biopharma and healthcare market. Pharmaceuticals, life sciences and healthcare companies are experiencing a wave of competing challenges currently.

Sharing her views on trends in biosuppliers Dr Deepanwita Chattopadhyay, Chairman & CEO, IKP Knowledge Park said “We have started producing the reagents in the country but a large amount is still being imported. I am seeing people getting into the reagents and suppliers business. It’s also about acceptance. The market depends also on buyers and not just sellers. If academic institutions and companies buy the Indian product and if they can establish the confidence then only their share in the market will increase. I think this process has already been started and slowly picking up.”

FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum

S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat

The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

US announces $50 B in awards to strengthen rural healthcare

The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.

time to read

1 min

February 2026

Bio Spectrum

WHO unveils Traditional Medicine Global Library

At the second WHO Global Summit on Traditional Medicine, jointly organised with the Government of India, concluding recently in New Delhi, WHO unveiled the Traditional Medicine (TM) Global Library (GL), a first-of-its-kind digital platform consolidating 1.6 million resources on TM, from scientific studies to indigenous knowledge.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Telangana sets global ambition with Life Sciences Policy 2026-30 targeting $25 B investments

The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum Annual Meeting in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

WHO reveals major equity gaps in human genomics research

The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits

US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio

Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Translate

Share

-
+

Change font size